// App-Quantinova.ai

: It is Not the N Status but the Lymph Node Ratio to Determine Survival and Recurrence Patterns in Resected Distal Cholangiocarcinoma

Researchers

Presenter

  • M. Di Martino

Principal Investigators

  • K.M. Chin

  • A. Manzoni

  • A. Benedetti Cacciaguerra

  • N. Syn

  • Y.-X. Koh

  • M. Prieto

  • M. Abu Hilal

  • B. Ielpo

Medical Centers

  • Singapore General Hospital, Department of Hepatopancreatobiliary and Transplant Surgery, Singapore, Singapore

  • University Hospital, Southampton, England, United Kingdom

  • Hospital Univesitario Cruces, Spain

  • Fondazione Poliambulanza Istituto Ospedaliero Multispecialistico, Italy

  • Hospital del Mar, Spain

Locations

  • Singapore

  • Italy

  • United Kingdom

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Infectious Diseases (ID)

Disease

  • Systemic inflammation

  • Advanced biliary tract carcinoma

Biomarkers

  • Neutrophil lymphocyte ratio

  • Platelet-lymphocyte ratio

  • Lymph node ratio

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved